Cargando…
Gestational diabetes mellitus in the COVID‐19 pandemic: A retrospective study from Hangzhou, China
AIMS: Our study aimed to investigate changes in the prevalence of gestational diabetes mellitus (GDM) in the COVID‐19 pandemic and postpandemic era and the risk of adverse pregnancy outcomes in pregnant women diagnosed with GDM during the blockade period. METHODS: First, we investigated changes in t...
Autores principales: | , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Wiley Publishing Asia Pty Ltd
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9574731/ https://www.ncbi.nlm.nih.gov/pubmed/36181374 http://dx.doi.org/10.1111/1753-0407.13324 |
_version_ | 1784811166126571520 |
---|---|
author | Yin, Binbin Wu, Kaiqi Hu, Lingwei Zheng, Wanlu Zheng, Yidan Duan, Xiuzhi Zhu, Bo |
author_facet | Yin, Binbin Wu, Kaiqi Hu, Lingwei Zheng, Wanlu Zheng, Yidan Duan, Xiuzhi Zhu, Bo |
author_sort | Yin, Binbin |
collection | PubMed |
description | AIMS: Our study aimed to investigate changes in the prevalence of gestational diabetes mellitus (GDM) in the COVID‐19 pandemic and postpandemic era and the risk of adverse pregnancy outcomes in pregnant women diagnosed with GDM during the blockade period. METHODS: First, we investigated changes in the prevalence of GDM and the population undergoing oral glucose tolerance tests (OGTT) after the COVID‐19 pandemic. We then collected clinical information from pregnant women diagnosed with GDM to explore the risk of adverse pregnancy outcomes in pregnant women with GDM during the COVID‐19 pandemic. RESULTS: After the COVID‐19 pandemic, the proportion of pregnant women in the total number of outpatient OGTT tests decreased yearly. The ratio was 81.30%, 79.71%, and 75.48% from 2019 to 2021, respectively, with the highest proportion of pregnant women in February 2020 (92.03%). The prevalence of GDM was higher in March 2020 compared to the same period in 2019. However, from 2019 to 2021, the prevalence decreased year by year with 21.46%, 19.81%, and 18.48%, respectively. The risk of adverse pregnancy outcomes for pregnant women diagnosed with GDM during the most severe period of the COVID‐19 pandemic did not differ from before the COVID‐19 pandemic. CONCLUSIONS: After the COVID‐19 pandemic, the prevalence of GDM increased during the most severe period of the epidemic, but the overall prevalence of GDM decreased year by year. In addition, the pandemic did not change the risk of adverse pregnancy outcomes in pregnant women with GDM. |
format | Online Article Text |
id | pubmed-9574731 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | Wiley Publishing Asia Pty Ltd |
record_format | MEDLINE/PubMed |
spelling | pubmed-95747312022-10-17 Gestational diabetes mellitus in the COVID‐19 pandemic: A retrospective study from Hangzhou, China Yin, Binbin Wu, Kaiqi Hu, Lingwei Zheng, Wanlu Zheng, Yidan Duan, Xiuzhi Zhu, Bo J Diabetes Original Articles AIMS: Our study aimed to investigate changes in the prevalence of gestational diabetes mellitus (GDM) in the COVID‐19 pandemic and postpandemic era and the risk of adverse pregnancy outcomes in pregnant women diagnosed with GDM during the blockade period. METHODS: First, we investigated changes in the prevalence of GDM and the population undergoing oral glucose tolerance tests (OGTT) after the COVID‐19 pandemic. We then collected clinical information from pregnant women diagnosed with GDM to explore the risk of adverse pregnancy outcomes in pregnant women with GDM during the COVID‐19 pandemic. RESULTS: After the COVID‐19 pandemic, the proportion of pregnant women in the total number of outpatient OGTT tests decreased yearly. The ratio was 81.30%, 79.71%, and 75.48% from 2019 to 2021, respectively, with the highest proportion of pregnant women in February 2020 (92.03%). The prevalence of GDM was higher in March 2020 compared to the same period in 2019. However, from 2019 to 2021, the prevalence decreased year by year with 21.46%, 19.81%, and 18.48%, respectively. The risk of adverse pregnancy outcomes for pregnant women diagnosed with GDM during the most severe period of the COVID‐19 pandemic did not differ from before the COVID‐19 pandemic. CONCLUSIONS: After the COVID‐19 pandemic, the prevalence of GDM increased during the most severe period of the epidemic, but the overall prevalence of GDM decreased year by year. In addition, the pandemic did not change the risk of adverse pregnancy outcomes in pregnant women with GDM. Wiley Publishing Asia Pty Ltd 2022-10-01 /pmc/articles/PMC9574731/ /pubmed/36181374 http://dx.doi.org/10.1111/1753-0407.13324 Text en © 2022 The Authors. Journal of Diabetes published by Ruijin Hospital, Shanghai JiaoTong University School of Medicine and John Wiley & Sons Australia, Ltd. https://creativecommons.org/licenses/by/4.0/This is an open access article under the terms of the http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited. |
spellingShingle | Original Articles Yin, Binbin Wu, Kaiqi Hu, Lingwei Zheng, Wanlu Zheng, Yidan Duan, Xiuzhi Zhu, Bo Gestational diabetes mellitus in the COVID‐19 pandemic: A retrospective study from Hangzhou, China |
title | Gestational diabetes mellitus in the COVID‐19 pandemic: A retrospective study from Hangzhou, China |
title_full | Gestational diabetes mellitus in the COVID‐19 pandemic: A retrospective study from Hangzhou, China |
title_fullStr | Gestational diabetes mellitus in the COVID‐19 pandemic: A retrospective study from Hangzhou, China |
title_full_unstemmed | Gestational diabetes mellitus in the COVID‐19 pandemic: A retrospective study from Hangzhou, China |
title_short | Gestational diabetes mellitus in the COVID‐19 pandemic: A retrospective study from Hangzhou, China |
title_sort | gestational diabetes mellitus in the covid‐19 pandemic: a retrospective study from hangzhou, china |
topic | Original Articles |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9574731/ https://www.ncbi.nlm.nih.gov/pubmed/36181374 http://dx.doi.org/10.1111/1753-0407.13324 |
work_keys_str_mv | AT yinbinbin gestationaldiabetesmellitusinthecovid19pandemicaretrospectivestudyfromhangzhouchina AT wukaiqi gestationaldiabetesmellitusinthecovid19pandemicaretrospectivestudyfromhangzhouchina AT hulingwei gestationaldiabetesmellitusinthecovid19pandemicaretrospectivestudyfromhangzhouchina AT zhengwanlu gestationaldiabetesmellitusinthecovid19pandemicaretrospectivestudyfromhangzhouchina AT zhengyidan gestationaldiabetesmellitusinthecovid19pandemicaretrospectivestudyfromhangzhouchina AT duanxiuzhi gestationaldiabetesmellitusinthecovid19pandemicaretrospectivestudyfromhangzhouchina AT zhubo gestationaldiabetesmellitusinthecovid19pandemicaretrospectivestudyfromhangzhouchina |